Back

Does the cardioprotective effect of Empagliflozin involve inhibition of the sodium-proton exchanger?

Cardiovascular Research

22 May 2021
Organised by: Logo
Read full article
ESC Journals

Contributors

Elizabeth Murphy
Elizabeth Murphy

Author

David A Eisner
David A Eisner

Author

You may be interested in
thumbnail
Congress Presentation
Empagliflozin in heart failure with preserved ejection fraction: decoding its molecular mechanism of action using artificial intelligence
29 June 2021
thumbnail
Congress Session
Young Investigator Award (YIA) Basic Science
17 May 2025
thumbnail
Congress Presentation
The effect of empagliflozin and dapagliflozin on the change of Na+-Li+-countertransport speed.
29 June 2021
thumbnail
Congress Presentation
SGLT2 inhibitors do not inhibit the cardiac sodium hydrogen exchanger (NHE1).
26 August 2022

ESC 365 is supported by

novartis Explore sponsored resources
novo-nordisk Explore sponsored resources